Uvavanyo oluKhawulezayo lwe-SARS-CoV-2 IgG/IgM
-
Uvavanyo oluKhawulezayo lwe-SARS-CoV-2 IgM/IgG Antibody
I-REF 502090 Inkcazo Iimvavanyo ezingama-20/Ibhokisi Umgaqo wokufumanisa Uvavanyo lwe-Immunochromatographic Imizekelo Igazi elipheleleyo / iSerum / iPlasma Usetyenziso olucetywayo Olu luvavanyo olukhawulezayo lwe-immuno-chromatographic ekubhaqweni ngaxeshanye kwe-IgM kunye ne-IgG antibodies kwi-SARS-CoV-2 intsholongwane egazini lomntu lonke, i-serum okanye iplasma. Uvavanyo lulinganiselwe e-US ukuba lusasazwe kwiilabhoratri eziqinisekiswe yi-CLIA ukwenza uvavanyo olunzima kakhulu.
Olu vavanyo aluzange luhlolwe yi-FDA.
Iziphumo ezibi aziluthinteli usulelo oluqatha lwe-SARS-CoV-2.
Iziphumo zovavanyo lwe-antibody akufuneki zisetyenziselwe ukuxilonga okanye ukungabandakanyi usulelo oluqatha lwe-SARS-CoV-2.
Iziphumo ezincumisayo zisenokuba ngenxa yosulelo lwangaphambili okanye lwangoku lohlobo lwe-coronavirus engeyiyo i-SARS-CoV-2, efana ne-coronavirus HKU1, NL63, OC43, okanye 229E.
